The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the China Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unresectable...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiao, Li, Rui-Sheng, Wang, Jian, Huang, Yin-Qiu, Li, Peng-Yan, Wang, Ji, Su, Hai-Bin, Wang, Rui-Lin, Zhang, Ya-Ming, Liu, Hong-Hong, Zhang, Cong-En, Ma, Zhi-Jie, Wang, Jia-Bo, Zhao, Yan-Ling, Xiao, Xiao-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814457/
https://www.ncbi.nlm.nih.gov/pubmed/27065861
http://dx.doi.org/10.3389/fphar.2016.00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814457/
https://www.ncbi.nlm.nih.gov/pubmed/27065861
http://dx.doi.org/10.3389/fphar.2016.00070

Ejemplares similares